IL12 is also involved in triggering IFN-Ɣ to switch CD4 helper differentiation into Th1 cells and was already described across expression signatures as a prognostic biomarker in NSCLC [53]. The gene discussed is CD4; the disease is non-small cell lung carcinoma.